However, some patients fail to complete IFN treatments because of adverse effects such as interstitial pneumonia (IP), which is known as a critical adverse effect and can lead to death [3], and cardiovascular events such as arrhythmia, which are rare among IFN-treated hepatitis C patients [4]. The gene discussed is IFNA1; the disease is Arrhythmia.